Wells Fargo
IDNA icon

Wells Fargo’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Wells Fargo’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$722K Buy
24,859
+1,313
+6% +$38.1K ﹤0.01% 3942
2025
Q4 		$617K Buy
23,546
+6,974
+42% +$179K ﹤0.01% 4328
2025
Q3 		$391K Buy
16,572
+1,638
+11% +$36.2K ﹤0.01% 4473
2025
Q2 		$306K Buy
14,934
+899
+6% +$18.1K ﹤0.01% 4487
2025
Q1 		$288K Buy
14,035
+1,086
+8% +$24.2K ﹤0.01% 4455
2024
Q4 		$293K Buy
12,949
+11,027
+574% +$265K ﹤0.01% 4547
2024
Q3 		$47.3K Buy
1,922
+426
+28% +$10.4K ﹤0.01% 5362
2024
Q2 		$34.6K Sell
1,496
-455
-23% -$10.7K ﹤0.01% 5423
2024
Q1 		$47K Sell
1,951
-1,908
-49% -$44.7K ﹤0.01% 5279
2023
Q4 		$88.8K Sell
3,859
-1,080
-22% -$21.7K ﹤0.01% 4977
2023
Q3 		$101K Sell
4,939
-5,809
-54% -$130K ﹤0.01% 4775
2023
Q2 		$251K Buy
10,748
+457
+4% +$11K ﹤0.01% 4444
2023
Q1 		$239K Buy
10,291
+3,272
+47% +$81.9K ﹤0.01% 4322
2022
Q4 		$177K Buy
7,019
+670
+11% +$18K ﹤0.01% 4239
2022
Q3 		$168K Sell
6,349
-447
-7% -$13.8K ﹤0.01% 4336
2022
Q2 		$196K Sell
6,796
-1,900
-22% -$56.7K ﹤0.01% 4292
2022
Q1 		$300K Sell
8,696
-14,029
-62% -$496K ﹤0.01% 4748
2021
Q4 		$996K Buy
+22,725
New +$1.08M ﹤0.01% 4110

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Wells Fargo's IDNA Position: Q1 2026 in Review

Wells Fargo increased its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 5.6% in Q1 2026, buying an estimated $38.1K and bringing the position to 24,859 shares worth $722K. The position accounts for ﹤0.01% of the portfolio, ranked #3942.

Wells Fargo first reported a position in IDNA in Q4 2021 and has held it in 18 quarters since. The position peaked at $996K in Q4 2021. 60 funds tracked by Wall St. Rank hold IDNA as of Q1 2026.

  • Wells Fargo held 24,859 shares of iShares Genomics Immunology and Healthcare ETF worth $722K as of Q1 2026.
  • Wells Fargo bought 1,313 iShares Genomics Immunology and Healthcare ETF shares in Q1 2026, an estimated $38.1K.
  • iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3942 holding.
  • Wells Fargo first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2021 and has held it in 18 quarters since.
  • Wells Fargo's iShares Genomics Immunology and Healthcare ETF position peaked at $996K in Q4 2021.
  • 60 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.